Related Experiment Video

Updated: Oct 17, 2026

Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis
06:28

Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis

Published on: November 10, 2023

Immunologic recovery of patients given CD34-selected peripheral blood progenitor cell transplantation for malignant

A Schulenburg, P Kalhs, N Worel

    Bone Marrow Transplantation
    |February 16, 2000
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    A Human Peripheral Blood Mononuclear Cell (PBMC) Engrafted Humanized Xenograft Model for Translational Immuno-oncology (I-O) Research
    08:17

    A Human Peripheral Blood Mononuclear Cell (PBMC) Engrafted Humanized Xenograft Model for Translational Immuno-oncology (I-O) Research

    Published on: August 15, 2019

    In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells
    05:32

    In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells

    Published on: February 16, 2024

    Related Experiment Videos

    Last Updated: Oct 17, 2026

    Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis
    06:28

    Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis

    Published on: November 10, 2023

    A Human Peripheral Blood Mononuclear Cell (PBMC) Engrafted Humanized Xenograft Model for Translational Immuno-oncology (I-O) Research
    08:17

    A Human Peripheral Blood Mononuclear Cell (PBMC) Engrafted Humanized Xenograft Model for Translational Immuno-oncology (I-O) Research

    Published on: August 15, 2019

    In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells
    05:32

    In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells

    Published on: February 16, 2024

    Related Concept Videos

    Bone Marrow Sampling and Transplants01:22

    Bone Marrow Sampling and Transplants

    Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
    The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...

    Articles linked to this work by shared authors, journal, and citation graph.

    Fresh or frozen grafts for allogeneic stem cell transplantation: conceptual considerations and a survey on the practice during the COVID-19 pandemic from the EBMT Infectious Diseases Working Party (IDWP) and Cellular Therapy & Immunobiology Working Party (CTIWP).

    Bone marrow transplantation·2023

    Consensus statement for cancer patients requiring intensive care support.

    Annals of hematology·2018

    High proportion of patients with bleeding of unknown cause in persons with a mild-to-moderate bleeding tendency: Results from the Vienna Bleeding Biobank (VIBB).

    Haemophilia : the official journal of the World Federation of Hemophilia·2018

    Caplacizumab reduces the frequency of major thromboembolic events, exacerbations and death in patients with acquired thrombotic thrombocytopenic purpura.

    Journal of thrombosis and haemostasis : JTH·2017

    JACIE accreditation for blood and marrow transplantation: past, present and future directions of an international model for healthcare quality improvement.

    Bone marrow transplantation·2017

    Long-term follow-up of a retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic transplantation from matched related donors in myelodysplastic syndromes.

    Bone marrow transplantation·2017

    A multimodal approach to sexual function after allogeneic hematopoietic stem cell transplantation: a randomized controlled trial.

    Bone marrow transplantation·2026

    How could calreticulin-targeting therapies change the myelofibrosis transplant paradigm?

    Bone marrow transplantation·2026

    The prognostic impact of CEBPA mutation in acute myeloid leukemia patients undergoing allogeneic hematopoietic stem cell transplantation.

    Bone marrow transplantation·2026

    Bridging therapy in pediatric and AYA patients under 25 years with relapsed/refractory B-ALL undergoing anti-CD19 CAR-T therapy: a multicenter retrospective study by the Spanish group GETH-TC.

    Bone marrow transplantation·2026

    Pleuroparenchymal fibroelastosis after allogeneic hematopoietic stem cell transplantation: Risk factors and longitudinal pulmonary function trajectories in a multicenter cohort.

    Bone marrow transplantation·2026

    Hyperacute Graft-Versus-Host Disease.

    Bone marrow transplantation·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us